2-es típusú cukorbetegség: vizsgálatok itt: Fülöp-szigetek
4 trials · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- City of Taguig, Dasmariñas, Davao City, Lipa City, Manila, Marikina City, Pasig, Quezon City, San Juan City
- Életkor
- 18 év and over
- People
- 11 800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00 - 3. fázisNot yet taking people in Fülöp-szigetekA Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus
- Where
- Davao City, Iloilo City, Manila
- Életkor
- 18 év and over
- People
- 351 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07775404 - No phaseTaking peopleiCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
- Where
- Bulacan, Cebu City, Iloilo City, Laguna, Mandaluyong, Manila, Mindoro, Pampanga, Quezon City, Zamboanga City
- Életkor
- 18 év and over
- People
- 35 000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT03549754 - No phaseNot yet taking people in Fülöp-szigetekA Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Participants
- Where
- Pasig
- Életkor
- 40 év to 70 év
- People
- 400 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07532863